These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1312093)

  • 21. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
    Spinner DS; Liu S; Wang SW; Schmidt J
    J Mol Biol; 2002 Mar; 317(3):431-45. PubMed ID: 11922675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the oligomerization of myogenin and E2A products in vivo using a two-hybrid assay system.
    Chakraborty T; Martin JF; Olson EN
    J Biol Chem; 1992 Sep; 267(25):17498-501. PubMed ID: 1325437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site.
    Wright WE; Binder M; Funk W
    Mol Cell Biol; 1991 Aug; 11(8):4104-10. PubMed ID: 1649388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR; Richardson JA; Klein WH; Olson EN
    Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo.
    Lassar AB; Davis RL; Wright WE; Kadesch T; Murre C; Voronova A; Baltimore D; Weintraub H
    Cell; 1991 Jul; 66(2):305-15. PubMed ID: 1649701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions among vertebrate helix-loop-helix proteins in yeast using the two-hybrid system.
    Staudinger J; Perry M; Elledge SJ; Olson EN
    J Biol Chem; 1993 Mar; 268(7):4608-11. PubMed ID: 8383120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural and synthetic DNA elements with the CArG motif differ in expression and protein-binding properties.
    Santoro IM; Walsh K
    Mol Cell Biol; 1991 Dec; 11(12):6296-305. PubMed ID: 1658630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the DNA-binding properties of MyoD, myogenin, and E12 by fluorescence anisotropy.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 2002 Sep; 41(35):10888-94. PubMed ID: 12196028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of myogenin gene expression during the embryonic development of the mouse.
    Yee SP; Rigby PW
    Genes Dev; 1993 Jul; 7(7A):1277-89. PubMed ID: 8391506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers.
    Sun XH; Baltimore D
    Cell; 1991 Jan; 64(2):459-70. PubMed ID: 1846322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis.
    Muscat GE; Rea S; Downes M
    Nucleic Acids Res; 1995 Apr; 23(8):1311-8. PubMed ID: 7753622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of muscle-specific transcription by myogenic helix-loop-helix proteins.
    Olson E
    Symp Soc Exp Biol; 1992; 46():331-41. PubMed ID: 1341046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding.
    Brennan TJ; Edmondson DG; Li L; Olson EN
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3822-6. PubMed ID: 1850837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions.
    Wright WE; Dac-Korytko I; Farmer K
    Dev Genet; 1996; 19(2):131-8. PubMed ID: 8900045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repression of muscle-specific gene activation by the murine Twist protein.
    Hebrok M; Füchtbauer A; Füchtbauer EM
    Exp Cell Res; 1997 May; 232(2):295-303. PubMed ID: 9168805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
    Voronova AF; Lee F
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A developmental and tissue-specific enhancer in the mouse skeletal muscle acetylcholine receptor alpha-subunit gene regulated by myogenic factors.
    Prody CA; Merlie JP
    J Biol Chem; 1991 Nov; 266(33):22588-96. PubMed ID: 1658001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12.
    Davis RL; Weintraub H
    Science; 1992 May; 256(5059):1027-30. PubMed ID: 1317057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection.
    Blackwell TK; Weintraub H
    Science; 1990 Nov; 250(4984):1104-10. PubMed ID: 2174572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A splice variant of the ITF-2 transcript encodes a transcription factor that inhibits MyoD activity.
    Skerjanc IS; Truong J; Filion P; McBurney MW
    J Biol Chem; 1996 Feb; 271(7):3555-61. PubMed ID: 8631961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.